Log In Sign up
The largest database of trusted experimental protocols

Mouse igg1κ isotype control antibody mopc21

Manufactured by BioLegend
Visit Supplier

The Mouse IgG1κ isotype control antibody (MOPC21) is a laboratory reagent used as a control in immunological experiments involving mouse IgG1κ antibodies. It serves as a reference to distinguish specific binding from non-specific background signals.

Automatically generated - may contain errors

Lab products found in correlation

Bw2258u89, by Phoenix Pharmaceuticals (2 mentions) Grp enzyme immunoassay eia, by Phoenix Pharmaceuticals (2 mentions)

Spelling variants of this product

Isotype control (56 citations) Isotype control antibody (45 citations) Mouse IgG1κ isotype (5 citations) Mouse IgG1κ isotype control antibody (4 citations) Isotype control mouse IgG1κ (2 citations)

2 protocols using mouse igg1κ isotype control antibody mopc21

1

GRP Enzyme Immunoassay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
GRP Enzyme ImmunoAssay (EIA), that is specific for the mature form of GRP (amide 1–27), was purchased from Phoenix Pharmaceuticals, Inc. (Catalog # EK-027–07; Burlingame, CA). The GRP inhibitor, NSC77427, was made by the Small Molecule Library Reagent Program (National Cancer Institute, Division of Cancer Treatment & Diagnosis/Developmental Therapeutics Program, NIH). The GRP receptor antagonist, BW2258U89, was purchased from Phoenix Pharmaceuticals, Inc. (Burlingame, CA). The anti-GRP antibody mouse monoclonal antibody, MoAb 2A11 (IgG1κ), was made by the National Cancer Institute, Center for Cancer Research, NCI-Navy Medical Branch and is also specific for the mature form of GRP.6 (link) Mouse IgG1κ isotype control antibody (MOPC21) was purchased from BioLegend (San Diego, CA). Both the MOPC21 and control antibody preparations were confirmed to be endotoxin-free by a chromogenic Limulus Amoebocyte Assay (ACC, East Falmouth, MA). The murine monoclonal mAb-2A11 (2A11) was provided by Dr. Cuttitta (NCI, NIH). Rabbit polyclonal anti-PGP 9.5 was obtained from Gene Technology Co., Ltd. (Shanghai, PRC).
Shirey K.A., Sunday M.E., Lai W., Patel M., Blanco J.C., Cuttitta F, & Vogel S.N. (2018). Novel Role of Gastric Releasing Peptide (GRP)-Mediated Signaling in the Host Response to Influenza Infection. Mucosal immunology, 12(1), 223-231.
+ Open protocol
+ Expand
2

GRP Enzyme Immunoassay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
GRP Enzyme ImmunoAssay (EIA), that is specific for the mature form of GRP (amide 1–27), was purchased from Phoenix Pharmaceuticals, Inc. (Catalog # EK-027–07; Burlingame, CA). The GRP inhibitor, NSC77427, was made by the Small Molecule Library Reagent Program (National Cancer Institute, Division of Cancer Treatment & Diagnosis/Developmental Therapeutics Program, NIH). The GRP receptor antagonist, BW2258U89, was purchased from Phoenix Pharmaceuticals, Inc. (Burlingame, CA). The anti-GRP antibody mouse monoclonal antibody, MoAb 2A11 (IgG1κ), was made by the National Cancer Institute, Center for Cancer Research, NCI-Navy Medical Branch and is also specific for the mature form of GRP.6 (link) Mouse IgG1κ isotype control antibody (MOPC21) was purchased from BioLegend (San Diego, CA). Both the MOPC21 and control antibody preparations were confirmed to be endotoxin-free by a chromogenic Limulus Amoebocyte Assay (ACC, East Falmouth, MA). The murine monoclonal mAb-2A11 (2A11) was provided by Dr. Cuttitta (NCI, NIH). Rabbit polyclonal anti-PGP 9.5 was obtained from Gene Technology Co., Ltd. (Shanghai, PRC).
Shirey K.A., Sunday M.E., Lai W., Patel M., Blanco J.C., Cuttitta F, & Vogel S.N. (2018). Novel Role of Gastric Releasing Peptide (GRP)-Mediated Signaling in the Host Response to Influenza Infection. Mucosal immunology, 12(1), 223-231.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!